Compared with non‐sarcopenia controls, sarcopenic muscle tissues exhibited elevated PAK4 protein levels and increased phosphorylation of its downstream target, AMPKα2‐S491, along with upregulation of MuRF1 and Atrogin‐1 (Figure 7A; Figure S14A). The gene discussed is PRKAA2; the disease is sarcopenia.